Dr. Sundas Khan
Overview
Sundas Khan is a Hematologist and an Oncologist in Lancaster, Pennsylvania. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. Her top areas of expertise are DICER1 Syndrome, HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, and Familial Colorectal Cancer. Dr. Khan is currently accepting new patients.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2102 Harrisburg Pike, Lancaster, PA 17601
Additional Areas of Focus
Dr. Khan has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins University
Robert Brodsky is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Brodsky is rated as an Elite provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is currently accepting new patients.
Geisinger Clinic
Mayur Patel is an Oncologist and a Hematologist in Coal Township, Pennsylvania. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Thrombocytopenia, Myelodysplastic Syndrome (MDS), Paget Disease of the Breast, and Angiosarcoma.
Penn Blood Disorders Center
Charles Abrams is a Hematologist in Philadelphia, Pennsylvania. Dr. Abrams is rated as an Advanced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Autoimmune Hemolytic Anemia, Shwartzman Phenomenon, Thrombocytopenia, and Venous Thromboembolism (VTE). Dr. Abrams is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- DICER1 SyndromeDr. Khan isAdvanced. Learn about DICER1 Syndrome.
- Experienced
- Atypical Hemolytic Uremic Syndrome (aHUS)
- BRCA Positive Breast CancerDr. Khan isExperienced. Learn about BRCA Positive Breast Cancer.
- D-Plus Hemolytic Uremic SyndromeDr. Khan isExperienced. Learn about D-Plus Hemolytic Uremic Syndrome.
- Familial Colorectal CancerDr. Khan isExperienced. Learn about Familial Colorectal Cancer.
- Hemolytic-Uremic SyndromeDr. Khan isExperienced. Learn about Hemolytic-Uremic Syndrome.
- HER2 Negative Breast CancerDr. Khan isExperienced. Learn about HER2 Negative Breast Cancer.